240 related articles for article (PubMed ID: 23430113)
1. Loss-of-function of the protein kinase C δ (PKCδ) causes a B-cell lymphoproliferative syndrome in humans.
Kuehn HS; Niemela JE; Rangel-Santos A; Zhang M; Pittaluga S; Stoddard JL; Hussey AA; Evbuomwan MO; Priel DA; Kuhns DB; Park CL; Fleisher TA; Uzel G; Oliveira JB
Blood; 2013 Apr; 121(16):3117-25. PubMed ID: 23430113
[TBL] [Abstract][Full Text] [Related]
2. Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation.
Ruiz-García R; Mora S; Lozano-Sánchez G; Martínez-Lostao L; Paz-Artal E; Ruiz-Contreras J; Anel A; González-Granado LI; Moreno-Pérez D; Allende LM
Pediatr Res; 2015 Dec; 78(6):603-8. PubMed ID: 26334989
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase cδ deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation.
Belot A; Kasher PR; Trotter EW; Foray AP; Debaud AL; Rice GI; Szynkiewicz M; Zabot MT; Rouvet I; Bhaskar SS; Daly SB; Dickerson JE; Mayer J; O'Sullivan J; Juillard L; Urquhart JE; Fawdar S; Marusiak AA; Stephenson N; Waszkowycz B; W Beresford M; Biesecker LG; C M Black G; René C; Eliaou JF; Fabien N; Ranchin B; Cochat P; Gaffney PM; Rozenberg F; Lebon P; Malcus C; Crow YJ; Brognard J; Bonnefoy N
Arthritis Rheum; 2013 Aug; 65(8):2161-71. PubMed ID: 23666743
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation.
Martínez-Feito A; Melero J; Mora-Díaz S; Rodríguez-Vigil C; Elduayen R; González-Granado LI; Pérez-Méndez D; Sánchez-Zapardiel E; Ruiz-García R; Menchén M; Díaz-Madroñero J; Paz-Artal E; Del Orbe-Barreto R; Riñón M; Allende LM
Immunobiology; 2016 Jan; 221(1):40-7. PubMed ID: 26323380
[TBL] [Abstract][Full Text] [Related]
5. Potentially Beneficial Effect of Hydroxychloroquine in a Patient with a Novel Mutation in Protein Kinase Cδ Deficiency.
Kiykim A; Ogulur I; Baris S; Salzer E; Karakoc-Aydiner E; Ozen AO; Garncarz W; Hirschmugl T; Krolo A; Yucelten AD; Boztug K; Barlan IB
J Clin Immunol; 2015 Aug; 35(6):523-6. PubMed ID: 26233237
[TBL] [Abstract][Full Text] [Related]
6. Sirolimus is effective in autoimmune lymphoproliferative syndrome-type III: A pedigree case report with homozygous variation PRKCD.
Gu H; Chen Z; Ma J; Wang J; Zhang R; Wu R; Wang T
Int J Immunopathol Pharmacol; 2021; 35():20587384211025934. PubMed ID: 34187243
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune lymphoproliferative syndrome mimicking chronic active Epstein-Barr virus infection.
Nomura K; Kanegane H; Otsubo K; Wakiguchi H; Noda Y; Kasahara Y; Miyawaki T
Int J Hematol; 2011 Jun; 93(6):760-764. PubMed ID: 21626105
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS).
Lisco A; Wong CS; Price S; Ye P; Niemela J; Anderson M; Richards E; Manion M; Mystakelis H; Similuk M; Lo B; Stoddard J; Rosenzweig S; Vanpouille C; Rupert A; Maric I; Perez-Diez A; Parenti D; Burbelo PD; Rao VK; Sereti I
Front Immunol; 2019; 10():1193. PubMed ID: 31191551
[TBL] [Abstract][Full Text] [Related]
9. The expanding spectrum of the autoimmune lymphoproliferative syndromes.
Oliveira JB
Curr Opin Pediatr; 2013 Dec; 25(6):722-9. PubMed ID: 24240292
[TBL] [Abstract][Full Text] [Related]
10. EBV Negative Lymphoma and Autoimmune Lymphoproliferative Syndrome Like Phenotype Extend the Clinical Spectrum of Primary Immunodeficiency Caused by STK4 Deficiency.
Schipp C; Schlütermann D; Hönscheid A; Nabhani S; Höll J; Oommen PT; Ginzel S; Fleckenstein B; Stork B; Borkhardt A; Stepensky P; Fischer U
Front Immunol; 2018; 9():2400. PubMed ID: 30386345
[TBL] [Abstract][Full Text] [Related]
11. Protein Kinase C-Delta Defect in Autoimmune Lymphoproliferative Syndrome-Like Disease: First Case from the National Iranian Registry and Review of the Literature.
Sharifinejad N; Azizi G; Behniafard N; Zaki-Dizaji M; Jamee M; Yazdani R; Abolhassani H; Aghamohammadi A
Immunol Invest; 2022 Feb; 51(2):331-342. PubMed ID: 33047643
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation.
Takagi M; Shinoda K; Piao J; Mitsuiki N; Takagi M; Matsuda K; Muramatsu H; Doisaki S; Nagasawa M; Morio T; Kasahara Y; Koike K; Kojima S; Takao A; Mizutani S
Blood; 2011 Mar; 117(10):2887-90. PubMed ID: 21063026
[TBL] [Abstract][Full Text] [Related]
13. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency.
Chun HJ; Zheng L; Ahmad M; Wang J; Speirs CK; Siegel RM; Dale JK; Puck J; Davis J; Hall CG; Skoda-Smith S; Atkinson TP; Straus SE; Lenardo MJ
Nature; 2002 Sep; 419(6905):395-9. PubMed ID: 12353035
[TBL] [Abstract][Full Text] [Related]
14. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
[TBL] [Abstract][Full Text] [Related]
15. Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.
Aspinall AI; Pinto A; Auer IA; Bridges P; Luider J; Dimnik L; Patel KD; Jorgenson K; Woodman RC
Blood Cells Mol Dis; 1999; 25(3-4):227-38. PubMed ID: 10575548
[TBL] [Abstract][Full Text] [Related]
16. Reversible monoclonal lymphadenopathy in autoimmune lymphoproliferative syndrome with functional FAS (CD95/APO-1) deficiency.
Ströbel P; Nanan R; Gattenlöhner S; Müller-Deubert S; Müller-Hermelink HK; Kreth HW; Marx A
Am J Surg Pathol; 1999 Jul; 23(7):829-37. PubMed ID: 10403307
[TBL] [Abstract][Full Text] [Related]
17. Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation.
Huck K; Feyen O; Niehues T; Rüschendorf F; Hübner N; Laws HJ; Telieps T; Knapp S; Wacker HH; Meindl A; Jumaa H; Borkhardt A
J Clin Invest; 2009 May; 119(5):1350-8. PubMed ID: 19425169
[TBL] [Abstract][Full Text] [Related]
18. Development of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome and associated Rosai-Dorfman disease.
Venkataraman G; McClain KL; Pittaluga S; Rao VK; Jaffe ES
Am J Surg Pathol; 2010 Apr; 34(4):589-94. PubMed ID: 20216376
[TBL] [Abstract][Full Text] [Related]
19. FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome.
Kuehn HS; Caminha I; Niemela JE; Rao VK; Davis J; Fleisher TA; Oliveira JB
J Immunol; 2011 May; 186(10):6035-43. PubMed ID: 21490157
[TBL] [Abstract][Full Text] [Related]
20. Mutation of FAS, XIAP, and UNC13D genes in a patient with a complex lymphoproliferative phenotype.
Boggio E; Aricò M; Melensi M; Dianzani I; Ramenghi U; Dianzani U; Chiocchetti A
Pediatrics; 2013 Oct; 132(4):e1052-8. PubMed ID: 24043286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
